کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4172082 | 1275718 | 2015 | 6 صفحه PDF | دانلود رایگان |
Inherited disorders that affect mitochondrial function are an exceedingly diverse group of conditions with different pathophysiological mechanisms and highly variable clinical phenotypes. Paediatric patients may present with a defined clinical syndrome or, more commonly, with non-specific signs of mitochondrial disease. Recognition of mitochondrial disease relies on having a high index of suspicion when faced with a multisystem disorder of unclear aetiology, in addition to knowledge of the various defined mitochondrial clinical syndromes. However, diagnosis remains a particular challenge, owing to the lack of sensitive and specific biomarkers. Evidence of mitochondrial dysfunction should be sought from a variety of organ systems using both functional and biochemical testing, although recent advances in genomic technology are changing the approach to diagnosis. Treatment of mitochondrial disease also presents a significant challenge, since although a few disease specific therapies exist, treatment remains predominantly supportive. Some cofactors, vitamins and antioxidants are commonly used to enhance mitochondrial function, although there is little evidence to support their efficacy.
Journal: Paediatrics and Child Health - Volume 25, Issue 3, March 2015, Pages 133–138